In the same manner and in a rat model of type 2 diabetic nephropathy, Xu and colleagues demonstrated that Pioglitazone can significantly reduce the hyperactivation of VEGFA in kidneys (26). This evidence concerns the gene VEGFA and type 2 diabetes nephropathy.